In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer

Immune checkpoint inhibitors exhibit limited response rates in patients with triple-negative breast cancer (TNBC), suggesting that additional immune escape mechanisms may exist. Here, we performed two-step customized in vivo CRISPR screens targeting disease-related immune genes using different mouse...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Peng, Gong, Yue, Jin, Ming-liang, Wu, Huai-liang, Guo, Lin-Wei, Pei, Yu-Chen, Chai, Wen-Jun, Jiang, Yi-Zhou, Liu, Yin, Ma, Xiao-Yan, Di, Gen-Hong, Hu, Xin, Shao, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242595/
https://www.ncbi.nlm.nih.gov/pubmed/35767614
http://dx.doi.org/10.1126/sciadv.abl8247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242595/
https://www.ncbi.nlm.nih.gov/pubmed/35767614
http://dx.doi.org/10.1126/sciadv.abl8247

Ejemplares similares